Full Text View
Tabular View
No Study Results Posted
Related Studies
Open Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation
This study has been completed.
Study NCT01599923   Information provided by Instituto Bioclon S.A. de C.V.

First Received on May 14, 2012.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Scorpion Sting Envenomation
Additional conditions recognized in this trial
Bites and Stings
More general conditions related to this trial
Poisoning
Substance-Related Disorders
Wounds and Injuries
Additional drug interventions recognized in this trial
Antivenins
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Instituto Bioclon S.A. de C.V.
University of Arizona
Instituto de Biotecnologia UNAM


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services